Stock EURO EURO-MED LABORATORIES PHIL., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Euro-Med Laboratories Phil., Inc. Share Price

Equities

EURO

PHY2352T1098

Pharmaceuticals

End-of-day quote Philippines S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
0.78 PHP +6.85% Intraday chart for Euro-Med Laboratories Phil., Inc. +5.41% +4.00%
04-15 Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Financials

Sales 2022 4.22B 73.22M 5.84B Sales 2023 5.26B 91.24M 7.28B Capitalization 3.08B 53.46M 4.27B
Net income 2022 200M 3.47M 277M Net income 2023 290M 5.03M 401M EV / Sales 2022 1.53 x
Net Debt 2022 2.87B 49.82M 3.98B Net Debt 2023 2.96B 51.23M 4.09B EV / Sales 2023 1.15 x
P/E ratio 2022
17.9 x
P/E ratio 2023
10.7 x
Employees 1,604
Yield 2022
4.02%
Yield 2023
-
Free-Float 11.69%
More Fundamentals * Assessed data

Chart Euro-Med Laboratories Phil., Inc.

Dynamic Chart

Latest news about Euro-Med Laboratories Phil., Inc.

Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Euro-Med Laboratories Phil., Inc. Approves Cash Dividend, Payable on 21 November 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Euro-Med Laboratories Phil., Inc. Approves Declaration of Cash Dividend as of 31 December 2020, Paid on 24 January 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Euro-Med Laboratories Phil., Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
Euro-Med Laboratories Phil., Inc. Appoints Mr. Anthony Joseph Y. Gaw as Director CI
More news

Press releases Euro-Med Laboratories Phil., Inc.

Euro Med Laboratories Phil : Change in External Auditor PU
Euro Med Laboratories Phil : Notice of Annual or Special Stockholders' Meeting PU
Euro Med Laboratories Phil : Material Information/Transactions PU
More press releases

Quotes and Performance

1 day+6.85%
1 week+5.41%
Current month-1.27%
1 month-1.27%
3 months-2.50%
6 months-10.34%
Current year+4.00%
More quotes

Highs and lows

1 week
0.73
Extreme 0.73
0.79
1 month
0.73
Extreme 0.73
0.79
Current year
0.71
Extreme 0.71
0.80
1 year
0.70
Extreme 0.7
0.88
3 years
0.70
Extreme 0.7
2.15
5 years
0.70
Extreme 0.7
4.49
10 years
0.70
Extreme 0.7
4.49
More quotes

Managers and Directors - Euro-Med Laboratories Phil., Inc.

Managers TitleAgeSince
Georgiana Evidente PSD
 President 63 31/12/89
Jose Emiterio CMP
 Compliance Officer 73 31/12/06
Evangeline Baviera BRD
 Director/Board Member 69 31/12/89
Members of the board TitleAgeSince
Johnny Yap BRD
 Director/Board Member 52 31/12/92
Basilio Yap BRD
 Director/Board Member 75 17/06/14
William Padolina CHM
 Chairman 77 31/12/89
More insiders

Quotes

Date Price Change Volume
26/04/24 0.78 +6.85% 20,000
25/04/24 0.73 0.00% 0
24/04/24 0.73 -7.59% 6,000
23/04/24 0.79 +6.76% 23,000
22/04/24 0.74 0.00% 33,000

End-of-day quote Philippines S.E., April 25, 2024

More quotes

Company Profile

Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

1st Jan change Capi.
EURO-MED LABORATORIES PHIL., INC. Stock Euro-Med Laboratories Phil., Inc.
+4.00% 55.52M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+11.97% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EURO Stock